Clinical Trial Update: Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of food on the pharmacokinetics of abiraterone acetate in patients with castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: University of Chicago | Conditions: Castration-resistant Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-05